logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
E

Emmanuel S. Antonarakis

university of minnesota

82H-index
1.1KPaper Count
3.5WCitation Count
Published Papers 243
Publication Date
logo
ERBB2/HER2 landscape and prognostic impact: large-scale, real-world analysis across solid cancers
errESMO Open
IF8.3
err2026-06-15
err0
errOAAI
errA. Shreenivas; A. Elliott; T. Corbiere; H.-Z. Chen; B. George; M. Kamgar; S. Chakrabarti; A. Desai; D. Bracken-Clarke; E. Xue; C.S. Floudas; J. Thomas; J. Xiu; G. Sledge; E.S. Antonarakis; Y. Boumber; R. Kurzrock
errShare
errSave
Molecular and clinical correlates of high FOLH1 (PSMA) RNA expression in primary and metastatic prostate cancer
errThe Oncologist
IF0
err2025-11-11
err0
errOAAI
errRana R McKay, MD; Shayan S Nazari, PhD; Andrew Elliott, PhD; Jennifer R Ribeiro, PhD; Brent S Rose, MD; Pedro C Barata, MD, MSc; Deepak Kilari, MD; Rohan Garje, MD; Neeraj Agarwal, MD; Norm Smith, MD; Emmanuel S Antonarakis, MD; Aditya Bagrodia, MD; Himisha Beltran, MD
errShare
errSave
HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer
errProstate Cancer and Prostatic Diseases
IF5.8
err2025-10-25
err0
errOAAI
errPornlada Likasitwatanakul; Carissa Besonen; Alexander K. Tsai; Negar Sadeghipour; Andrew Elliott; Ali T. Arafa; Rachel Passow; Lisa Chesner; Martin Felices; Philippa R. Kennedy; Akash Patnaik; Vivek Narayan; James Hamrick; Laura A. Sena; Nicholas A. Zorko; Justin H. Hwang; Emmanuel S. Antonarakis
errShare
errSave
Proteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular Subtypes
errJournal of Extracellular Vesicles
IF14.5
err2025-10-08
err0
errOAAI
errMegan L. Ludwig; Ali T. Arafa; Saasha Vinoo; Jason C. Jones; Abderrahman Day; Hannah E. Bergom; Zoi Sychev; Alec Horrmann; Nicholas M. Levinson; Scott M. Dehm; Emmanuel S. Antonarakis; Justin Hwang; Justin M. Drake
errShare
errSave
Novel MAML2 Fusions in Human Malignancy
errCancers 2025, Vol. 17, Page 3146
IF4.4
err2025-09-28
err0
errOAAI
errTakefumi Komiya; Kieran Sweeney; Chao H. Huang; Anthony Crymes; Emmanuel S. Antonarakis; Andrew Elliott; Matthew J. Oberley; Mark G. Evans
errShare
errSave
IUC24429-86 Real-world use of bone-modifying agents (BMA) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the United States
errThe Oncologist
IF0
err2025-08-29
err0
errOAAI
errZ I Ozay; Y Jo; M Ostrowski; N Sayegh; R Graf; S Roy; E Antonarakis; R McKay; N Agarwal; U Swami
errShare
errSave
CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer
errnpj Precision Oncology
IF8
err2025-08-06
err0
errOAAI
errAllison Makovec; Ella Boytim; Ava Gustafson; Megan Ludwig; Liangjun Wang; Atef Ali; Khalid Ishani; Christine Luo; Hannah E. Bergom; Emily John; Sydney Tape; Samuel Kellen; Aiden Deacon; Fatemah Iman Dewji; Camden Richter; Lauren Cookle; David Moline; Jonathan P. Rennhack; Justin M. Drake; Emmanuel S. Antonarakis; David A. Largaespada; Julie H. Ostrander; Justin Hwang
errShare
errSave
Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate Cancer
errEuropean Urology Oncology
IF9.3
err2025-07-19
err0
errOAAI
errNiven Mehra; Emmanuel S. Antonarakis; Se Hoon Park; Jeffrey C. Goh; Ray McDermott; Nuria Sala Gonzalez; Peter C. Fong; Richard Greil; Maria De Santis; Patricio Eduardo Yanez; Yi-Hsiu Huang; Stephen D. Begbie; Felipe Rey; Gero Kramer; Hiroyoshi Suzuki; Todd L. Saretsky; Sameer R. Ghate; Yi Cui; Christian Hosius; Evan Y. Yu
errShare
errSave
Uncovering PD-L1 among immune cell predictive biomarkers and actionable genetic alterations in anal squamous-cell carcinomas in the era of immunotherapy
errESMO Open
IF8.3
err2025-06-01
err0
errOAAI
errG. Sharma; Y. Baca; A.F. Shields; A. Prakash; B.A. Weinberg; A. Saeed; S. Goel; A. Abdalla; M. Oberley; J. Xiu; J. Hwang; E.S. Antonarakis; V.K. Chiu; E. Lou
errShare
errSave
CHD1 status drives divergent metabolic pathways in SPOP-mutant prostate cancer. Cancer genetics
errNATURE CANCER
IF28.5
err2025-05-13
err0
PREAI
errOrme, Jacob J.; Antonarakis, Emmanuel S.
errShare
errSave
Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomes
errONCOLOGIST
IF4.2
err2025-04-22
err0
errOAAI
errIranmanesh, Yasaman; Omar, Noha; Rasouli, Arya; Baras, Alex; Pasca, Sergiu; Gondek, Lukasz P.; Tsai, Hua-Ling; Denmeade, Samuel R.; Carducci, Michael A.; Paller, Channing J.; Markowski, Mark C.; Luo, Jun; Eisenberger, Mario A.; Antonarakis, Emmanuel S.
errShare
errSave
Radiotherapeutics, clonal hematopoiesis, and risk of hematologic malignancies: The good, the bad, the ugly
errBLOOD REVIEWS
IF5.7
err2025-03-01
err2
PREAI
errMarshall, Catherine H.; Antonarakis, Emmanuel S.; Patnaik, Mrinal M.
errShare
errSave
Case Report: Prepubertal-type testicular teratoma with local metastasis in a postpubertal patient
errFRONTIERS IN ONCOLOGY
IF3.3
err2025-02-25
err0
errOAAI
errGhirardelli Smith, Olivia C.; Tsai, Alexander K.; Zhong, Minghao; Dejban, Pegah; Nelson, Andrew C.; Dolan, Michelle; Antonarakis, Emmanuel S.; Murugan, Paari
errShare
errSave
Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after 177Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes
errEuropean Urology Oncology
IF9.3
err2025-02-07
err0
PREAI
errRuben Raychaudhuri; Abuzar Moradi Tuchayi; Soon Khai Low; Ali T. Arafa; Laura S. Graham; Roman Gulati; Colin C. Pritchard; Robert B. Montgomery; Michael C. Haffner; Peter S. Nelson; Evan Y. Yu; Jessica E. Hawley; Heather H. Cheng; George Mo; Delphine L. Chen; Emmanuel S. Antonarakis; Deepak Kilari; Thomas A. Hope; Amir Iravani; Michael T. Schweizer
errShare
errSave
Biomonitoring PhIP, a Potential Prostatic Carcinogen, in the Hair of Healthy Men of African and European Ancestry
errTOXICS
IF4.1
err2025-01-08
err0
errOAAI
errTuresky, Robert J.; Jones, Clarence; Guo, Jingshu; Cammerrer, Kari; Maertens, Laura A.; Antonarakis, Emmanuel S.; Lu, Zhanni; Spector, Logan G.
errShare
errSave
AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients
errNATURE COMMUNICATIONS
IF15.7
err2024-12-11
err0
errOAAI
errKnutson, Todd P.; Luo, Bin; Kobilka, Anna; Lyman, Jacqueline; Guo, Siyuan; Munro, Sarah A.; Li, Yingming; Heer, Rakesh; Gaughan, Luke; Morris, Michael J.; Beltran, Himisha; Ryan, Charles J.; Antonarakis, Emmanuel S.; Armstrong, Andrew J.; Halabi, Susan; Dehm, Scott M.
errShare
errSave
Intratumoral heterogeneity drives acquired therapy resistance in a patient with metastatic prostate cancer
errNPJ PRECISION ONCOLOGY
IF8
err2024-12-02
err0
errOAAI
errRhinehart, Dena P.; Lai, Jiaying; Sanin, David E.; Vakkala, Varsha; Mendes, Adrianna; Bailey, Christopher; Antonarakis, Emmanuel S.; Paller, Channing J.; Wu, Xiaojun; Lotan, Tamara L.; Karchin, Rachel; Sena, Laura A.
errShare
errSave
Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024
errCANCER
IF5.1
err2024-12-01
err0
PREAI
errBryce, Alan H.; Agarwal, Neeraj; Beltran, Himisha; Hussain, Maha H.; Sartor, Oliver; Shore, Neal; Antonarakis, Emmanuel S.; Armstrong, Andrew J.; Calais, Jeremie; Carducci, Michael A.; Dorff, Tanya Barauskas; Efstathiou, Jason A.; Gleave, Martin; Gomella, Leonard G.; Higano, Celestia; Hope, Thomas A.; Iagaru, Andrei; Morgans, Alicia K.; Morris, David S.; Morris, Michael J.; Petrylak, Daniel P.; Reiter, Robert E.; Rettig, Matthew B.; Ryan, Charles J.; Sellinger, Scott B.; Spratt, Daniel E.; Srinivas, Sandy; Tagawa, Scott T.; Taplin, Mary-Ellen; Yu, Evan Y.; Zhang, Tian; Mckay, Rana R.; Koo, Phillip J.; Crawford, E. David
errShare
errSave
Current Treatment Paradigms and Clinical Outcomes in Oligometastatic Prostate Cancer Patients: A Targeted Literature Review
errEUROPEAN UROLOGY ONCOLOGY
IF9.3
err2024-12-01
err0
PREAI
errAntonarakis, Emmanuel S.; Shui, Irene M.; Zaidi, Omer; Bernauer, Mark; Gratzke, Christian
errShare
errSave
Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer
errEuropean Urology Oncology
IF9.3
err2024-12-01
err0
PREAI
errFrancesca Zacchi; Wassim Abida; Emmanuel S. Antonarakis; Alan H. Bryce; Elena Castro; Heather H. Cheng; Shahneen Shandhu; Joaquin Mateo
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
B
Bert Vogelstein
H-index: 255 · Papers: 1.0K
R
Ralph H. Hruban
H-index: 209 · Papers: 2.0K
M
Mark A. Rubin
H-index: 186 · Papers: 1.5K
H
Howard I. Scher
H-index: 164 · Papers: 1.4K
D
Drew M. Pardoll
H-index: 164 · Papers: 892
View more